Blackstone Group on Thursday announced its decision to acquire BioMed Realty Trust for $4.8 billion, in a deal valued at nearly $8 billion including debt. The price is at a 24% premium to BioMed's undisturbed share price on September 22. The trust provides office space to medical and healthcare companies, and will be another addition to Blackstone's large real-estate portfolio.